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Lamin A/C is a major component of the nuclear lamina. An intact nuclear lamina has been proposed to be necessary for muscle dif-
ferentiation. Cyclin D3 is known to be upregulated in differentiated muscle cells and to form insoluble complexes with cell-cycle regu-
latory factors in these cells. We have examined the possibility of direct binding interactions between lamin A/C and cyclin D3 by in vitro
binding assays and co-immunoprecipitation studies with muscle cells. Our results indicate that cyclin D3 binds specifically to amino acid
residues 383–474 of lamin A/C and associates with lamin A/C in muscle cells. The identification of cyclin D3 as a novel binding partner
of lamin A/C has important implications for a role for lamin A/C in muscle differentiation.
 2007 Elsevier Inc. All rights reserved.
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group of proteins termed the lamins, which belong to the
intermediate filament superfamily of proteins. Lamins are
important for nuclear integrity and are involved in the
organization of nuclear processes; increasing evidence sug-
gests that lamins can also interact directly with proteins
that function in diverse cellular pathways [1,2]. The A-type
lamins (A and C) are 3 0 alternately spliced forms of the
lamin A gene and have been detected primarily in differen-
tiated cells. Mutations in the human lamin A/C gene have
been linked to at least 10 highly degenerative, heritable dis-
orders. As the majority of mutations cause Emery–Dreifuss
muscular dystrophy (EDMD), there has been considerable
interest in understanding a possible role for lamin A/C in
muscle differentiation. Lamin A/C knock-out mice develop
muscular dystrophy symptoms resembling EDMD [3].
Myoblasts from Lmna/ mice show impaired differentia-
tion [4] and expression of lamin A mutants results in inhi-
bition of myoblast differentiation [2,5,6].0006-291X/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2007.02.060
Abbreviations: Cdk, cyclin-dependent kinase; EDMD, Emery–Drei-
fuss muscular dystrophy; GST, glutathione-S-transferase; pRb, retino-
blastoma protein.
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E-mail address: veenap@ccmb.res.in (V.K. Parnaik).We have earlier shown that internal lamins are reorga-
nized to a diffuse network during the differentiation of
C2C12 myoblasts [7]. This process required cyclin D3
and retinoblastoma protein (pRb), which were sequestered
on the insoluble nuclear matrix [8]. Cyclin D3 behaves as
an atypical cyclin in muscle cells as it is activated several-
fold when myoblasts differentiate [9], and a role for cyclin
D3 in the induction and/or maintenance of terminal differ-
entiation in both muscle and non-muscle cells has been
proposed [10]. In this study, we have examined the possibil-
ity that cyclin D3 binds directly to lamin A/C by carrying
out in vitro binding assays and co-immunoprecipitation
experiments. Our data indicates that cyclin D3 binds spe-
cifically to amino acid residues 383–474 of lamin A/C
and interacts with lamin A/C in muscle cells.
Materials and methods
Plasmid constructs. Restriction fragments of lamin A cDNA were
subcloned into pGEX vectors as described earlier [11]. Restriction frag-
ments of cyclin D3 (from pRC-CMV-cycD3-HA, provided by P. Hinds,
Harvard Medical School, MA) and the cyclin D3 K112E mutant [8] were
subcloned into pET vectors.
In vitro binding assays. Recombinant pGEX and pET clones were
expressed in Escherichia coli BL21(DE3)-pLys(S). Cells expressing pGEX
clones were lysed in 100 mM EDTA, 1% Triton X-100, 10 mM sodium
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protease inhibitors. The supernatants were incubated with glutathione
agarose beads for 2–3 h at 4 C, centrifuged and washed with lysis buffer.
Subsequently, cultures of induced pET clones were lysed in 20 mM Hepes,
pH 7.2, 0.4 mM EDTA, 1% Triton X-100, 10 mM NaF, 150 mM NaCl,
0.5 mM Na3VO4, 1 mM PMSF, 0.5 mM DTT, and protease inhibitors.
The supernatants were incubated with equal quantities of beads bound to
either GST or GST-fusion proteins for 3 h at 4 C, centrifuged and washed
with lysis buffer, separated by SDS–PAGE and analyzed by
immunoblotting.
Cell culture, extraction and DNA transfections. C2C12 mouse skeletal
myoblasts were maintained in DMEM containing 20% FBS and induced
to differentiate by transfer to DMEM containing 2% horse serum for 48 h.
Cells plated on coverslips were extracted with 0.4% Triton X-100, followed
by nucleases and 2 M NaCl as described [12], fixed with formaldehyde and
immunostained. Transient transfection of myoblasts with pRC-CMV-
cycD3-HA was carried out with Lipofectamine (Invitrogen).
Immunochemical techniques. Immunofluorescence assays were carried
out as described [8]. Samples were viewed on a Zeiss LSM510 META
confocal microscope (Carl Zeiss, Oberkochen, Germany). Immunoblot
analysis was carried out as described [8]. For immunoprecipitation assays,
the procedure described by Capanni et al. [13] was used with small
modifications. Briefly, cells were lysed with cold buffer containing 50 mM
Tris–HCl, pH 7.4, 500 mM NaCl, 5 mM MgCl2, 1% Triton X-100, 5 mM
ATP, 1 mM PMSF, 50 mM NaF, 0.1 mM Na3VO4, and protease inhibi-
tors. The precleared samples were immunoprecipitated with primary
antibody followed by protein A-sepharose beads and the bound proteins
were analyzed by immunoblotting. The primary antibodies used were
polyclonal antibodies to lamin A/C or HA epitope tag from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA), mouse monoclonal antibodies to
cyclin D3 from Cell Signaling Technology (Beverly, MA) and to the T7
fusion peptide from Novagen (Madison, WI).
Results
In vitro interactions of lamin A and cyclin D3
We initially determined whether cyclin D3 could bind
directly to lamin A in a solid-phase binding assay. When
bacterial lysates of pET-expressed cyclin D3 were incu-
bated with full-length GST-lamin A bound to glutathione
agarose beads, cyclin D3 was detected in the bound frac-
tion (Fig. 1A and B). This interaction was specific as bind-
ing was not observed with GST alone. To delineate theFig. 1. Binding assays with lamin A fragments. (A) Coomassie-blue stained g
probed with anti-T7 antibody. (C) Summary of data. Molecular mass markers
carbonic anhydrase, 30 kDa.binding site on lamin A, GST was fused with deletion frag-
ments of lamin A encompassing different domains [1,2,14].
In binding assays with these fragments, the smallest frag-
ment of lamin A which demonstrated specific binding to
cyclin D3 was narrowed down to amino acid residues
383–474 (Fig. 1A and B). This region is common to both
lamin A and C as lamin C encompasses residues 1–566 of
lamin A followed by six unique residues.
Next, various deletion and mutant constructs of cyclin
D3 were expressed in the pET vector and binding assays
were carried out with GST-lamin 356–665 (which was con-
venient to use experimentally as it was more soluble than
full-length lamin A). Both wild-type cyclin D3 and the
kinase inactive K112E mutant associated specifically with
GST-lamin 356–665, whereas binding to lysates expressing
the empty pET vector was negligible (Fig. 2). Also, both N-
terminal and C-terminal deletion fragments of cyclin D3
displayed binding to GST-lamin 356–665.Association of cyclin D3 with lamin A/C in mammalian cells
Although endogenous cyclin D3 is known to form insol-
uble complexes with cell cycle regulatory factors in differen-
tiated muscle cells [15], its pattern of localization in nuclear
matrices prepared from differentiated cells has not been
reported. We have analyzed the expression and location
of endogenous cyclin D3 in C2C12 myotubes that have
been extracted with detergent and treated with nucleases
and salt to remove soluble nuclear components. Cyclin
D3 was detected in a punctate stained pattern in insoluble
nuclear matrix preparations, at levels comparable to those
observed in unextracted differentiated cells (Fig. 3). Lamin
A/C was detected in a typical pattern at the nuclear rim.
Extracted samples were observed to be depleted of DNA
as a negative control. Myoblasts expressed very low levels
of cyclin D3, as expected.
To determine whether cyclin D3 interacted with lamin
A/C in vivo, lysates of myotubes were immunoprecipitatedel of purified GST-lamin fragments. (B) Immunoblot of bound cyclin D3
are: phosphorylase b, 94 kDa; albumin 67 kDa; ovalbumin, 45 kDa; and
Fig. 2. Binding assays with cyclin D3 fragments. (A) Input cyclin D3 fragments and (B) cyclin D3 fragments bound to GST-lamin 356–665, detected by
immunoblotting with anti-T7 antibody. (C) Summary of data. Asterisk, non-specific protein.
Fig. 3. Association of cyclin D3 with the nuclear matrix. Immunostaining of cyclin D3 and lamin A/C in unextracted and extracted samples of (A) C2C12
myotubes and (B) myoblasts. Bar, 10 lm.
Fig. 4. Co-immunoprecipitation of cyclin D3 and lamin A/C. Lysates from (A) C2C12 myotubes or (B) cyclin D3-transfected myoblasts were
immunoprecipitated with antibodies to lamin A/C, HA tag or control IgG and analyzed by immunoblotting with the indicated antibodies. Asterisk, IgG.
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blotting for the presence of cyclin D3. Endogenous cyclin
D3 was detectable in the lamin A/C immunoprecipitate,as shown in Fig. 4. These proteins were not immunoprecip-
itated with purified normal IgG used as a control, thus con-
firming the specificity of the interaction between cyclin D3
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blasts ectopically expressing HA-tagged cyclin D3 were
immunoprecipitated with antibodies to HA or lamin A/C
in separate reactions and analyzed by Western blotting.
Both cyclin D3 and lamins A and C were detectable in
the HA immunoprecipitate. Conversely, lamins A and C
as well as cyclin D3 were detectable in the lamin A/C
immunoprecipitate. These data indicate that cyclin D3
and lamin A/C interact in vivo.
Discussion
Our present findings demonstrate that cyclin D3 binds
to amino acid residues 383–474 of lamin A/C in in vitro
binding assays. Furthermore, this interaction is physiolog-
ically relevant as endogenous lamin A/C and cyclin D3 are
co-immunoprecipitated from mammalian cell lysates.
Lamin A/C has been shown to bind to gene regulatory
factors such as pRb, SREBP1, MOK2, and c-Fos and
modulate their activities [16–19]. The binding region for
both pRb and MOK2 spans coil 2 of the rod domain,
whereas the binding site for c-Fos has been narrowed down
to the Ig-fold domain (436–544). The smallest fragment,
lamin 383–474, that we have determined to bind to cyclin
D3 is in the globular tail domain in a region common to
lamin A and C, and excludes the rod domain as well as
most of the Ig-fold. This segment includes the NLS for
lamin A/C at position 417–422 as well as a putative chro-
matin-binding domain between residues 396–430 [20].
Interestingly, the segment from 386–402, which is rich in
arginine residues, has been proposed to be involved in asso-
ciations of lamin dimers [21]. Furthermore, phosphoryla-
tion of the critical Ser 392 residue during mitosis causes
dissociation of linear lamin polymers [22]. The arginine res-
idues at 386 and 453 positions are critical for physiological
functions as the R386K and R453W mutations cause
EDMD [23]. Expression of these mutants has deleterious
effects on muscle differentiation in cultured cells [2,5];
moreover, R386K assembles into large aggregates, leading
to abnormal nuclear morphology. Thus, the 383–474 seg-
ment is an important region for protein–protein
interactions.
Cyclin D3 associates with a number of cell cycle regula-
tory proteins such as cdks, cdk inhibitors, and pRb [15,24].
Binding of cyclin D3 has also been demonstrated for the
small retinoic acid-binding protein, CRABPII [25], the
p28 subunit of eukaryotic initiation factor 3 (eIF3k) [26],
and p58PITSLRE, a G2/M specific kinase [27]. Our binding
data indicates that segment 76–292 of cyclin D3, which
lacks the pRb-binding site at residues 3–7 [24] is able to
bind to lamin A/C. Thus, the region of cyclin D3 that binds
to lamin A/C does not overlap with the pRb-binding
domain of cyclin D3.
In earlier studies, pRb has been shown to bind to resi-
dues 247–355 of lamin A/C [16]. Our finding that cyclin
D3 binds to residues 383–474 of lamin A/C indicates that
pRb and cyclin D3 bind to non-overlapping, contiguousregions of lamin A/C. Thus our binding data and co-immu-
noprecipitation analysis are consistent with the formation
of a multimeric complex of cyclin D3, pRb and lamin A/
C in muscle cells, which has important implications for a
role for lamin A/C in muscle differentiation.
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